S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 DiaMedica TherapeuticsContraFectSernovaBio-PathSierra Oncology
SymbolNASDAQ:DMACNASDAQ:CFRXOTCMKTS:SEOVFNASDAQ:BPTHNASDAQ:SRRA
Price Information
Current Price$2.60$0.32$0.18$10.65$0.31
52 Week RangeBuyBuyN/ABuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyBuy
Consensus Price Target$9.33$1.75N/A$28.00N/A
% Upside from Price Target258.97% upside446.53% upsideN/A162.91% upsideN/A
Trade Information
Market Cap$28.94 million$25.43 million$35.40 million$31.05 million$22.65 million
Beta2.770.151.133.211.28
Average Volume67,190794,44630,2431,373,214564,094
Sales & Book Value
Annual Revenue$500,000.00N/AN/A$40,000.00N/A
Price / Sales62.44N/AN/A767.87N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.43 per share$0.07 per share$0.02 per share$1.79 per share$1.27 per share
Price / Book1.82N/AN/A5.95N/A
Profitability
Net Income$-5,730,000.00$-37,680,000.00$-2,870,000.00$-8,580,000.00$-53,330,000.00
EPSN/A($0.37)N/A($14.38)($0.75)
Trailing P/E Ratio0.00N/A0.00N/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)-82.50%-120.64%-110.35%-84.81%-64.97%
Return on Assets (ROA)-69.70%-30.51%-95.89%-76.39%-56.38%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.01%0.37%N/A0.02%0.06%
Current Ratio12.96%4.15%4.36%18.01%9.24%
Quick Ratio12.96%4.15%4.36%18.01%9.24%
Ownership Information
Institutional Ownership Percentage10.70%34.94%N/A9.48%52.28%
Insider Ownership Percentage12.80%6.50%N/A8.65%5.61%
Miscellaneous
Employees920N/A879
Shares Outstanding12.01 million79.41 million196.66 million2.88 million74.69 million
Next Earnings Date11/12/2019 (Estimated)11/14/2019 (Estimated)2/21/2020 (Estimated)11/21/2019 (Estimated)11/14/2019 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableNot OptionableOptionable
 DiaMedica TherapeuticsContraFectSernovaBio-PathSierra Oncology

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel